Rating History for BridgeBio Oncology Therapeutics, In (BBOT) by Canaccord
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/11/2026 | John Newman | New Coverage | Buy (N/A) |
23.00 (N/A) |
7.66 (7.50) |
-2.09% | Details |
